Dale Broadrick, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 20,000 shares at $1.54 ($32K) on 2023-09-14, disclosed to the SEC on 2023-09-18.
Open-market purchase of $32k BRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.54 | 10,000 | $15K | 48.1% |
| 2 | $1.66 | 10,000 | $17K | 51.9% |
| Total | $1.60 avg | 20,000 | $32K | 100% |
| Filing → |
| BRTX | BUY | 2024-02-09 | $325K | — | Filing → |
| BRTX | SELL | 2023-12-05 | $470 | — | Filing → |
| BRTX | SELL | 2023-12-01 | $525 | — | Filing → |